Endocrine System
BNF Chapter 06
Items (National)
141.3M
NHS Cost
£1,993.7M
Substances
139
Sections
7
The Endocrine System chapter of the BNF contains 139 chemical substances prescribed across England, totalling 141,349,866 items at a cost of £1,993,748,787 to the NHS.
Sections
| Section | Items | Cost | Substances |
|---|---|---|---|
| Drugs used in diabetes | 73.9M | £1,585.8M | 58 |
| Thyroid and antithyroid drugs | 35.4M | £57.8M | 7 |
| Corticosteroids (endocrine) | 8.0M | £31.5M | 16 |
| Sex Hormones | 17.4M | £244.2M | 25 |
| Hypothalamic and pituitary hormones and anti, oestrogens | 371.5K | £37.3M | 12 |
| Drugs affecting bone metabolism | 6.1M | £31.5M | 11 |
| Other endocrine drugs | 112.2K | £5.7M | 10 |
Top Drugs in Endocrine System
| Drug | Items | Cost |
|---|---|---|
| Levothyroxine sodium | 34.5M | £42.7M |
| Metformin hydrochloride | 26.6M | £81.6M |
| Dapagliflozin | 8.9M | £322.1M |
| Prednisolone | 6.4M | £13.8M |
| Gliclazide | 6.0M | £13.6M |
| Estradiol | 5.7M | £82.1M |
| Glucose blood testing reagents | 5.5M | £73.5M |
| Alendronic acid | 5.1M | £6.9M |
| Finasteride | 4.5M | £4.9M |
| Empagliflozin | 4.3M | £163.5M |
| Progesterone | 2.9M | £41.7M |
| Linagliptin | 2.7M | £78.4M |
| Insulin aspart | 2.6M | £111.5M |
| Sitagliptin | 2.6M | £5.7M |
| Estradiol with progestogen | 2.3M | £69.8M |
| Insulin glargine | 2.0M | £88.8M |
| Semaglutide | 1.6M | £145.6M |
| Alogliptin | 1.4M | £38.1M |
| Tirzepatide | 1.3M | £137.2M |
| Canagliflozin | 847.8K | £33.7M |